USD 32 billion
Type 2 Diabetes Market Size, Share, Growth Analysis, By Drug Class(Dipeptidyl Peptidase-4 Inhibitors, Glucagon-like Peptide 1 Receptor Agonists, Biguanides, Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors), By Route of Administration(Oral, Parenteral), By Distribution Channel(Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End User(Homecare Settings, Hospitals & Clinics, Academic & Research Institutes, Others), By Region - Industry Forecast 2025-2032
Report ID:
SQMIG35J2115 |
Region:
Global |
Published Date: October, 2024
Pages:
216
|Tables:
94
|Figures:
77
Type 2 Diabetes Market Insights
Type 2 Diabetes Market size was valued at USD 36.87 Billion in 2023 and is poised to grow from USD 39.72 Billion in 2024 to USD 71.66 Billion by 2032, growing at a CAGR of 7.72% during the forecast period (2025-2032).
The major factor driving the type 2 diabetes market growth forward is the rising incidence of T2D across the globe. As the incidence of T2D worldwide continues to grow, the global needs for effective treatment options continue to increase accordingly. Moreover, pharmaceutical companies are supporting the growth of the market by developing new drugs. Importantly, new drugs such as sodium-glucose cotransporter-2 (SGLT2) inhibitors such as Jardiance and glucagon-like peptide-1 receptor agonists Tanzeum and Trulicity have provided significant advances in the management of diabetes. These have increasingly been gaining popularity for they provide better alternatives for treatment to patients with fewer side effects. Nevertheless, the availability and these new treatments' advantages are completely unknown to patients, which is a problem for the market, and could prevent their widespread adoption. In these countries, however, rising medical requirements provide a prime future scope for the industry in terms of expansion. Currently, people are in immediate need of affordable and highly advanced treatment opportunities which is significantly increasing with increasing number of diabetics there. Technological advancements are mainly transforming the future of treatment of diabetes by providing various customized and elastic alternatives. With increasing use of mobile health applications, related devices, and cloud-based enterprise solutions, the market is increasing because it has brought the most effective and accessible treatments to patients across the globe.
Market snapshot - 2025-2032
Global Market Size
Largest Segment
Oral
Fastest Growth
Parenteral
Growth Rate
8.20% CAGR
Global Type 2 Diabetes Market ($ Bn)
Country Share for North America (%)
To get more reports on the above market click here to Buy The Report
Type 2 Diabetes Market Segmental Analysis
Global Type 2 Diabetes Market is segmented by Drug Class, Route of Administration, Distribution Channel, End User, and Region. Based on Drug Class, the market is segmented into Dipeptidyl Peptidase-4 Inhibitors, Glucagon-like Peptide 1 Receptor Agonists, Biguanides, Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors, Others. Based on Route of Administration, the market is segmented into Oral, Parenteral. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, Online Pharmacies. Based on End User, the market is segmented into Homecare Settings, Hospitals & Clinics, Academic & Research Institutes, Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Analysis by Route of Administration
Based on the type 2 diabetes market analysis, the most common and widely used route of diabetic drug administration is oral, especially for the treatment of type 2 diabetes (T2D). As they are non-invasive and easy to use, people opt for oral drugs such as metformin, sulfonylureas, and more recent types such as DPP-4 inhibitors. Patients can take these medications at home without a doctor's supervision because they are usually accessible as pills or capsules. Oral medicines are often prescribed as first-line treatments for type 2 diabetes because they are effective in managing blood sugar levels. The increasing number of diabetes patients worldwide and the ongoing development of more advanced oral medicines aimed at improving treatment outcomes are the primary growth drivers of this category.
However, as more advanced and targeted treatments are developed, parenteral administration-including injectable drugs such as insulin and GLP-1 receptor agonists (e.g., Trulicity, Ozempic), is expected to rise. Parenteral therapies offer greater precision and efficacy in managing blood glucose levels but are typically reserved for more severe cases of diabetes. Patients with type 1 diabetes or those whose type 2 diabetes is poorly controlled should be especially attentive to this strategy. Patients now have greater access to and acceptance of these treatments because of technological advances such as easier-to-use insulin pumps and pen injectors. The increasing use of biologic therapy and a general trend toward injectable medications for better blood sugar management are the primary drivers of this growth.
Analysis By Distribution Channel
As per the type 2 diabetes market forecast, the hospital pharmacies segment is one of the major sources of diabetic drugs, especially for patients requiring specialist care or those newly diagnosed and needing immediate access to treatment. For patients with severe diabetes or those requiring hospitalization, these pharmacies typically stock a broader selection of injectable medications, including insulin, GLP-1 receptor agonists, and other biologics. Healthcare providers in hospitals can help patients better understand their treatment options and improve drug monitoring and adherence. Even though this channel is crucial for critical and acute care, as more patients are now seeking outpatient treatment, its expansion is being slightly constrained. Hospital pharmacies are still essential for the treatment of complicated or serious diabetic patients, though.
Contrarily, the retail pharmacies category is anticipated to grow and expand. With relative ease, these pharmacy outlet stores offer a great amount of oral diabetic agents which include DPP-4 inhibitors, SGLT2 inhibitors, as well as metformin recommended for the long-term treatment and control of diabetes. Many customers prefer retail pharmacies because they offer the convenience of filling prescriptions without going to a hospital. Retail pharmacies are becoming more prominent in providing accessible and affordable diabetic medicines as chronic disease management and outpatient care increase. This channel is expected to continue growing because of patient preferences for affordability and convenience.
Global Type 2 Diabetes Market By Route of Administration
To get detailed analysis on other segments, Request For Free Sample Report
Type 2 Diabetes Market Regional Insights
In 2022, North America was the market leader for type 2 diabetes, accounting for 35% of the revenue share. The expansion of this market is driven by the rapid rise in the prevalence of diabetes in this region. More than 29 million people in North America are thought to have diabetes at the moment, and by 2025, that figure is predicted to increase to 32 million, which will increase demand for diabetes care goods and services. Diabetes is one of the key market drivers, as more than 25 million people suffer from the disease in the US alone in 2019. North America is dominant due to its high prevalence, increasing awareness, availability of advanced therapies, and a strong healthcare system. Availability of newer pharmaceutical treatments and the increasing use of digital health solutions also add to the region's market growth.
The type 2 diabetes market is expected to develop at the fastest rate in Europe throughout the forecast period. This rise is caused mainly by the rising incidence of type 2 diabetes patients throughout the continent. The UK dominates the European market, with a large percentage of its population suffering from diabetes. With the growth of the number of diabetics and diabetes incidence, it is urgent that there arise efficient therapies along with management policies. European health care systems have started becoming increasingly interested in preventive interventions and improved education about the illness for the patient and its availability for dealing with the illness. Consequently, the future for type 2 diabetes market will increase with its growth mainly through the increased governmental concerns and better attention towards healthy lifestyles, growing awareness within healthcare services.
Global Type 2 Diabetes Market By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Type 2 Diabetes Market Dynamics
Drivers
Increased Prevalence of Type 2 Diabetes
-
One of the main reasons driving the market is the globally increasing incidence of type 2 diabetes. More people are developing type 2 diabetes due to unhealthy lifestyles, age, and the rise of obesity. This is bringing in a huge patient pool that is highly demanding about diabetic drugs, monitoring tools, and advanced therapies thereby driving the development and growth of this market in both developed as well as developing nations.
Increased Requirement for Insulin
-
The type 2 diabetes market category provides growth opportunities for the insulin industry. Many people suffer from type 2 diabetes. It is a significant reason for the increasing demand for insulin drugs. Due to the diversity and innovation of its products, the insulin industry has vast growth and development opportunities. Therefore, during the forecast period, the global type 2 diabetes industry is expected to increase due to an increase in demand for insulin.
Restraints
Inadequate Healthcare Facilities in Some Countries
-
The healthcare system is not up to the mark in some cases of diabetes. It is a major constraint for the type 2 diabetes market. Poor health infrastructure does not allow proper research, drug development, and other activities of the market. The type 2 diabetes market may not be able to grow in some areas because of the lack of health infrastructure. In addition, demand may be lower in other places. Therefore, due to a lack of health care infrastructure in certain countries, the expansion of the type 2 diabetes market is being hindered.
High Cost of Medical Treatment
-
Perhaps the biggest challenge the type 2 diabetes industry faces are high treatment costs, particularly of recently discovered drugs and more advanced monitoring tools. Certain medications, such as insulin pumps, continuous glucose monitors, and several drugs for diabetes, like SGLT2 inhibitors or GLP-1 receptor agonists, have higher costs that restrict their access to patients and the healthcare system, especially in low-income communities, and slow up the adoption of more innovative and efficient strategies for controlling this disease.
Request Free Customization of this report to help us to meet your business objectives.
Type 2 Diabetes Market Competitive Landscape
Major pharmaceutical companies such as Novo Nordisk, Eli Lilly, Sanofi, and AstraZeneca define this competitive landscape in the type 2 diabetes market because they dominate with their varieties of innovative medicines such as GLP-1 receptor agonists and SGLT2 inhibitors. These business entities focus on increasing their product offerings, improving outcomes for patients, and searching for new treatment options. Competition is becoming keener due to the emergence of digital health solutions because technical-driven companies are entering into the market.
Top Player’s Company Profiles
- Novo Nordisk
- Sanofi
- Eli Lilly and Company
- Merck & Co., Inc.
- Boehringer Ingelheim
- AstraZeneca PLC
- Novartis AG
- GlaxoSmithKline plc
- Pfizer Inc.
- Daiichi Sankyo Company, Limited
- Roche Holding AG
- Sun Pharmaceutical Industries Ltd.
- Lupin Limited
- Dr. Reddy's Laboratories Ltd.
- Aurobindo Pharma Limited
- Medtronic
- B. Braun Melsungen AG
- Abbott Laboratories
- F. Hoffmann-La Roche
- Insulet Corporation
Recent Developments
- Novo Nordisk's Ozempic launch, semaglutide launched in July 2023, is a great improvement in the management of risk of cardiovascular events in Type 2 diabetes patients. With its once-weekly injectable GLP-1 receptor agonist, this may well be an added success in Novo Nordisk's efforts to enhance patients' outcomes and deal with diabetes-related cardiovascular problems.
- Sanofi's FDA approval of Toujeo® Max SoloStar® in November 2022 is a significant development in the Type 2 diabetes industry. The launch of Toujeo® Max SoloStar®, an insulin glargine injection with three times the maximum dosage of Toujeo® SoloStar®, significantly expands Sanofi's diabetes drug portfolio. Patients with Type 2 diabetes enjoy better glucose control and greater dosage flexibility with this injection.
- Eli Lilly's acquisition of Protomer Technologies in March 2021 is a strategic move toward innovative diabetic solutions. Protomer Technologies is specialized in peptide engineering. Its distinct molecular engineering platform may lead to better diabetes treatments, such as insulin that reacts to glucose. This acquisition shows Eli Lilly's dedication to creating innovative new strategies for treating Type 2 diabetes, which is promising for future therapeutic developments.
Type 2 Diabetes Key Market Trends
- Remote Monitoring and Digital Health: In the management of Type 2 diabetes, digital health solutions such as wearable technology and mobile applications are increasingly being applied. These technologies enable patients to monitor their glucose level continuously and share real-time data with healthcare providers. Remote monitoring helps patients track blood sugar levels, medication adherence, and overall health, thereby improving care through more proactive management of the disease. This leads to reduced healthcare costs along with better patient outcomes and increased engagement.
- GLP-1 Agonists and SGLT-2 Inhibitors: GLP-1 receptor agonists and SGLT-2 inhibitors are increasingly being used in the treatment of Type 2 diabetes. These drugs offer cardiovascular and renal protection besides better glucose management, which is especially beneficial for patients who also have heart or kidney disease. These medications are thus being prescribed more frequently, which is growing the demand for more recent and efficient diabetic treatments that target more than just glucose regulation.
Type 2 Diabetes Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected using Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the type 2 diabetes market outlook is witnessing rapid change with the passage of time, due to rapid technological advancement and treatment alternatives. It means digital health solutions are turning out to be transformative in changing diabetes management, thereby ensuring that better patient outcomes and better patient involvement occur. Moreover, new entrants such as SGLT-2 inhibitors and GLP-1 receptor agonists are transforming the face of treatment, providing health benefits for the kidneys and the heart combined with effective glucose control. A combination of better therapies and technologically advanced solutions will be needed as the market grows for improving patient care, reducing health costs, and combating increasing global incidence of Type 2 diabetes.
| Report Metric | Details |
|---|---|
| Market size value in 2023 | USD 36.87 Billion |
| Market size value in 2032 | USD 71.66 Billion |
| Growth Rate | 7.72% |
| Base year | 2024 |
| Forecast period | 2025-2032 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Type 2 Diabetes Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Type 2 Diabetes Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Type 2 Diabetes Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Type 2 Diabetes Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Type 2 Diabetes Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Type 2 Diabetes Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
